High Prevalence of Chronic Diseases to Elevate Scope of Fluoroscopy and Mobile C-Arms Market
Market
Overview:
Fluoroscopy
can be defined as an imaging technique, which uses X-Ray technology for taking
real-time images of the body. It allows the physicians to visualize muscles,
organs, and bones, which further helps them to make crucial decisions during
surgery.
The
global Fluoroscopy
And Mobile C-Arms Market, as per a report by Market Research Future
(MRFR) is touted to register a CAGR of 4.58%, surpassing a valuation of USD
2,951.4 million during the forecast period (X).
Factors
like the rising incidence of chronic diseases, ever-increasing geriatric
population, and high adoption of fluoroscopy in neurological and orthopedic
procedures will supplement the market growth in the segment. Improving
healthcare infrastructure, advancing technology in fluoroscopy and C-arms
equipment, and increasing number of interventional radiology surgeries are
likely to elevate the scope for the market across the globe. Moreover, rapid
product launches and rising number of mergers and acquisitions will further
contribute to the market growth in the long run. The shift towards a
value-based healthcare model, surging adoption of minimally invasive surgeries,
and soaring demand for improved imaging technology are likely to promote the
market growth in the coming years.
On
the contrary, the high cost of fluoroscopic and mobile c-arm systems, coupled
with the risk of radiation exposure are some of the key concerns likely to
restrict the market growth across the globe.
Competitive
Dashboard:
·
Canon Medical Systems Corporation
·
Allengers Medical Systems
·
GE Healthcare
·
DMS Group
·
Hologic In
·
Hitachi Ltd
·
OrthoSca
·
Omega Medical Imaging
·
Shimadzu Corporation
·
Koninklijke Philips N.V.
·
Varian Medical System
·
Siemens
·
Ziehm Imaging GmbH
·
Villa Sistemi Medicali Spa
Global
Fluoroscopy and Mobile C-Arms Market: Segmental Analysis
·
The fluoroscopy and mobile C-arms market has
been segmented on the basis of application, device type, and end user.
·
By device type, the market is segmented into fluoroscopy
systems and mobile c-arms. Of these, the mobile C-arms segment will gain
significant prominence, mainly due to the soaring incidence of cardiovascular
disease and the rising number of orthopedic surgeries.
·
The market finds application in orthopedics,
gastrointestinal, cardiovascular, pain management and trauma, urology,
neurology, and others.
·
Based on the end users, the market constitutes
diagnostic centers, hospital and clinics, research and academic institutes, and
others.
Regional
Frontiers
Geographically,
the fluoroscopy and mobile C-arms market have been studied under regions
namely, Europe, the Americas, Asia Pacific, and the Middle East & Africa.
Considering
the global scenario, the Americas is predicted to acquire the lion’s share and
dominate the market globally. In this region, North America is predicted to command
the largest share, mainly due to the acceptance of innovative and latest products.
Also, the surging awareness regarding medical imaging devices and rising
financial capability to purchase expensive machines are driving the market
growth in the region.
Europe
is likely to register moderate growth in the foreseeable future. The regional
growth can be credited to the surging prevalence of road accidents, which leads
to orthopedic surgeries. The rising expenditure in the healthcare sector and increasing
R&D activities will further contribute to the market growth in the long
run.
Meanwhile,
the Asia Pacific will register the fastest growth across the globe. Developing
countries like India, China, and South Korea are gradually becoming major
destinations for pathology testing and outsourcing clinical trials. This is
likely to elevate the scope of the market in the region. The presence of
untapped opportunities, surging awareness about medical imaging techniques and
applications, and improving healthcare infrastructure are encouraging the
regional market’s growth.
Industry
Updates:
September 2019: ControlRad
has recently announced the completion of the first clinical use of its Trace
system. This Atlanta-based ControlRad’s Trace technology can be easily
integrated into mobile C-arms. It assists in reducing radiation in fluoroscopically
guided procedures and protect medical staff and patients, without hampering
image quality and workflow.
Comments
Post a Comment